ENGLISH

Hormone Therapy in Breast and Prostate Cancer

By V. Craig Jordan , Barrington J.A. Furr (auth.) , Barrington J.A. Furr (eds.)

Book information

Publisher
Humana Press
Year
2009
ISBN
1607614715, 9781607614715
DOI
10.1007/978-1-59259-152-7
Language
english
Format
PDF
Filesize
6 MB (6390828 bytes)
Series
Cancer Drug Discovery and Development
Edition
1
Pages
420\423
Topic
Medicine Oncology
Time added
2010-08-30 15:18:36
Oncology; Cancer Research; Pharmacology/Toxicology

Description

Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide. Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics.

Similar books